Clinical and economic outcomes from a community hospital's antimicrobial stewardship program

American Journal of Infection Control

Volumn 41, Issue 2, 2013, Pages 145-148

  Malani, Anurag N ^a   Richards, Patrick G ^a   Kapila, Shikha ^a   Otto, Michael H ^a   Czerwinski, Jennifer ^a   Singal, Bonita ^a  

^a Saint Joseph Mercy Health System   (United States)

Author keywords

Antimicrobial management; ASP; Clostridium difficile infection; Non university teaching hospital; Outcomes

Indexed keywords

AZTREONAM; CASPOFUNGIN; DAPTOMYCIN; ERTAPENEM; LINEZOLID; MEROPENEM; TIGECYCLINE; VORICONAZOLE;

ADULT; AGED; ANTIMICROBIAL STEWARDSHIP PROBRAM; ANTIMICROBIAL THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY HOSPITAL; CONSULTATION; CONTROLLED STUDY; COST CONTROL; CRITICALLY ILL PATIENT; DRUG COST; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; HEALTH CARE COST; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITAL READMISSION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PHARMACIST; PHYSICIAN; PRESCRIPTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG PRESCRIPTIONS; FEMALE; HEALTH CARE COSTS; HOSPITALS, COMMUNITY; HUMANS; MALE; MIDDLE AGED; ORGANIZATIONAL POLICY; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84873086898     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2012.02.021     Document Type: Article

References (16)

1. J.E. McGowan Jr. Minimizing antimicrobial resistance: the key role of the infectious diseases physician Clin Infect Dis 38 2004 939 942
2. National Nosocomial Infections Surveillance System National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004 Am J Infect Control 32 2004 470 485
3. T.H. Dellit, R.C. Owens, J.E. McGowan Jr., D.N. Gerding, R.A. Weinstein, and J.P. Burke Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 2007 159 177
4. L.L. Maragakis, E.N. Perencevich, and S.E. Cosgrove Clinical and economic burden of antimicrobial resistance Expert Rev Anti Infect Ther 6 2008 751 763
5. P. Carling, T. Fung, A. Killion, N. Terrin, and M. Barza Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years Infect Control Hosp Epidemiol 24 2003 699 706
6. A. LaRocco Jr. Concurrent antibiotic review programs: a role for infectious diseases specialists at small community hospitals Clin Infect Dis 37 2003 742 743
7. S. Ruttimann, B. Keck, C. Hartmeier, A. Maetzel, and H.C. Bucher Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital Clin Infect Dis 38 2004 348 356
8. C. Philmon, T. Smith, S. Williamson, and E. Goodman Controlling use of antimicrobials in a community teaching hospital Infect Control Hosp Epidemiol 27 2006 239 244
9. B. Johannsson, S.E. Beekmann, A. Srinivasan, A.L. Hersh, R. Laxminarayan, and P.M. Polgreen Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers Infect Control Hosp Epidemiol 32 2011 367 374
10. E.R. Dubberke, K.A. Reske, L.C. McDonald, and V.J. Fraser ICD-9 codes and surveillance for Clostridium difficile-associated disease Emerg Infect Dis 12 2006 1576 1579
11. D.B. Scheurer, L.S. Hicks, E.F. Cook, and J.L. Schnipper Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort Epidemiol Infect 135 2007 1010 1013
12. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
13. L. Valiquette, B. Cossette, M.P. Garant, H. Diab, and J. Pepin Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain Clin Infect Dis 45 2007 S112 S121
14. E.R. Dubberke, and A.I. Wertheimer Review of current literature on the economic burden of Clostridium difficile infection Infect Control Hosp Epidemiol 30 2009 57 66
15. S.H. Cohen, D.N. Gerding, S. Johnson, C. Kelly, V. Loo, and C. McDonald Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Infect Control Hosp Epidemiol 31 2010 431 455
16. E.R. Dubberke, A.M. Butler, D.S. Yokoe, J. Mayer, B. Hota, and J.E. Mangino Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes Infect Control Hosp Epidemiol 31 2010 262 268